New Key Statistics Module, Z-Score and F-Score
BJSE:833230 Key Ratios
Market Cap ¥ M | 996.07 |
Enterprise Value ¥ M | 969.85 |
P/E(ttm) | 50.66 |
PE Ratio without NRI | 50.27 |
Forward PE Ratio | -- |
Price/Book | 2.54 |
Price/Sales | 3.88 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.76 |
Revenue (TTM) ¥ M | 262.00 |
EPS (TTM) ¥ | 0.26 |
Beneish M-Score | -0.07 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 8.70 |
y-y EBITDA Growth Rate % | 1.70 |
EV-to-EBIT | 33.06 |
EV-to-EBITDA | 33.06 |
PEG | 5.78 |
Shares Outstanding M | 75.63 |
Net Margin (%) | 7.71 |
Operating Margin % | 8.49 |
Pre-tax Margin (%) | 8.87 |
Quick Ratio | 4.27 |
Current Ratio | 6.54 |
ROA % (ttm) | 4.67 |
ROE % (ttm) | 5.16 |
ROIC % (ttm) | 6.53 |
Dividend Yield % | 1.56 |
Altman Z-Score | 13.93 |
BJSE:833230 Number of Guru Trades
BJSE:833230 Volume of Guru Trades
Gurus Latest Trades with BJSE:833230
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BJSE:833230 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chengdu Okay Pharmaceutical Co Ltd Insider Transactions
No Available Data